期刊文献+

术前B型利钠肽水平预测冠状动脉旁路移植术后早期并发症:荟萃分析 被引量:3

A Meta-analysis of the Utility of Pre-operative Brain Natriuretic Peptide in Predicting Early Postoperative Complications in Patients with Coronary Artery Bypass Grafting
原文传递
导出
摘要 目的应用meta分析的方法评价术前B型利钠肽(BNP)水平在预测冠状动脉旁路移植术(CABG)术后早期并发症中的价值。方法计算机检索PubMed,Embase,Cochrane图书馆,中国期刊全文数据库及维普数据库,按照诊断试验的评价标准检索并筛选有关CABG术前BNP测定与术后早期并发症发生相关性的文献。根据QUADAS质量评价标准评价纳入文献的质量。采用Rev Man 5.2进行异质性检验及Meta-Disc1.4进行meta分析,对纳入文献进行加权定量合并,计算汇总灵敏度、特异度、诊断比值比、阳性似然比和阴性似然比及其95%可信区间(95%CI),绘制汇总受试者工作特征曲线(SROC),并计算曲线下面积(AUC)。结果检出相关文献259篇,根据纳入标准最终入选5篇文献;共入选病例548例,其中术后发生早期并发症者160例,未发生者388例;术前增加的BNP浓度与术后早期并发症发生的诊断比值比(DOR)为14.92[95%CI(9.13,24.37)];汇总灵敏度为0.86[95%CI(0.79,0.91)],汇总特异度为0.74[95%CI(0.69,0.78)],汇总阳性似然比为3.65[95%CI(2.23,5.97)],汇总阴性似然比为0.20[95%CI(0.14,0.29)];SROC曲线的AUC为0.9018(Q值为0.8331)。结论术前BNP水平升高与术后早期并发症具有明显的相关性,是术后早期并发症发生的强预测因子,可以高度预测术后早期并发症的发生。 Objective We conducted a meta-analysis of the utility ofpre-operative B-type natriuretic peptide (BNP) in predicting early postoperative complications in patients with coronary artery bypass grafting (CABG). Methods we searched PubMed, Embase, the Cochrane Controlled Trials Register databases, CNKI and VIP datebases, and we determined study eligibility and conducted data abstraction independently and in duplicate. We included the studies that the observational or randomized control trials measuring BNP concentrations in patients with CABG. The heterogeneity, sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, the area under the SROC (AUC) were analyzed by the software of Rev Man 5.2 and Meta-Disc1.4. Results Of 259 studies identified, 5 studies met eligibility criteria, and included a total of 548 patients, among whom 160 experienced early postoperative complications after CABG. Elevated pre-operative BNP were significantly associated with early postoperative complications after CABG (DOR: 14.92, P〈0.01). The pooled sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and the AUC were 0.86 [95%Cl(0.79, 0.91)], 0.74 [95%Cl(0.69, 0.78)], 3.65 [95%Cl(2.23, 5.97)], 0.20 [95%Cl(0.14, 0.29)] and 0.9018, respectively. Conclusions These results suggest that an elevated pre-operative BNP measurement is a powerful, independent predictor of early postoperative complications after CABG.
出处 《中国分子心脏病学杂志》 CAS 2013年第6期718-722,共5页 Molecular Cardiology of China
基金 中华医学会胸心血管外科分会厄尔巴肯科研奖学金(2011-H28#) 中央级公益性科研院所基本科研基金(2012F-015)
关键词 B型利钠肽 冠状动脉旁路移植术 术后并发症 B-type Natriuretic Peptide Coronary Artery Bypass Grafting Postoperative Complications
  • 相关文献

参考文献20

  • 1Aranki S F, Shaw D P, Adams D H, et al. Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. Circulation. 1996, 94(3): 390-397.
  • 2Hutfless R, Kazanegra R, Madani M, et al. Utility of b-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. J Am Coll Cardiol. 2004, 43(10): 1873-1879.
  • 3Sachdeva A, Horwich T B, Fonarow G C. Comparison of usefulness of each of five predictors of mortality and urgent transplantation in patients with advanced heart failure. Am J Cardiol. 2010, 106(6): 830-835.
  • 4Fellahi J L, Daccache G, Rubes D, et al. Does preoperative b-type natriuretic peptide better predict adverse outcome and prolonged length of stay than the standard european system for cardiac operative risk evaluation after cardiac surgery'? J Cardiothorac Vasc Anesth. 2011, 25(2): 256-262.
  • 5Whiting P, Rutjes A W, Rcitsma J B, et al. The development of quadas: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003, 3: 25.
  • 6Kerbaul F, Collart F, Giorgi R, et al. Increased plasma levels of pro- brain natriuretic peptide in patients with cardiovascular complications following off-pump coronary artery surgery. Intensive Care Med. 2004, 30(9): 1799-1806.
  • 7Suttner S, Boldt J, Lang K, et al. Association of n-terminal pro-brain natriuretic peptide and cardiac troponin t with in-hospital cardiac events in elderly patients undergoing coronary artery surgery. Eur J Anaesthesiol. 2008, 25(10): 834-841.
  • 8路亚枫,齐弘炜,汤楚中,吴明营,王阳,赵凤华.脑钠肽和内皮素在冠状动脉旁路移植术中的变化及意义[J].中国危重病急救医学,2007,19(11):667-670. 被引量:4
  • 9Ata Y, Turk T, Ay D, et al. Ability of b-type natriuretic peptide in predicting postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting, tteart Surg Forum. 2009, 12(4):E211-E216.
  • 10Blankenberg S, Tonkin A, Kirby A, et al. Incorporating novel biomarkers significantly improves risk stratification for coronary heart disease patients: the long-term intervention with pravastatin in ischaemic disease (lipid) trial. Circulation. 2011, 124(2 l).

二级参考文献10

  • 1汪芳,王莉,边文彦,顼志敏,李一石.慢性心力衰竭急性发作患者N端前脑钠素水平的变化[J].中国危重病急救医学,2006,18(4):195-198. 被引量:21
  • 2Berendes E.Schmidt C,Van Aken H,et al. A- type and B- type natriuretic peptides in cardiac surgical procedures[J]. Anesth Analg,2004.98(1) :11 - 19.
  • 3Ndrepepa G,Braun S,Mehilli J .et al. Plasma levels of N -terminal pro - brain natriuretic peptide in patients with coronary artery disease and relation to clinical presentation.angiographic severity. and left ventricular ejection fraction[J]. Am J Cardiol, 2005, 95(5):553 - 557.
  • 4Watanabe M. Egi K, Hasegawa S. et al. Slgnificance of serum atrial and brain natriuretic peptide release after coronary artery bypass grafting[J]. Surg Today,2003.33(9),671 - 673.
  • 5Hedman A, Larsson P T, Alam M, et al. CRP, IL - 6 and endothelin- 1 levels in patients undergoing coronary artery bypass grafting. Do preoperative inflammatory parameters predict early grafl occlusion and late cardiovascular events[J]? Int J Cardiol.2007.120(1):108- 114.
  • 6Mullani M M. lkonomidis J S. Kim P Y. et al. Dynamic and differential changes in myocardial and plasma endothelin in patients undergoing cardiopulmonary bypass[J]. J Thorac Cardiovasc Surg.2005.129(3) :584 - 590.
  • 7Shimada Y. Yaku H. Shuntoh K. et al. Impact of myocardial angiotensin converting enzyme activity on coronary vascular resistance and serum brain natriuretic peptide peptide concentration in coronary bypass surgery[J]. Circ J, 2003, 67 (5): 379 - 383.
  • 8Provenchere S. Berroeta C. Reynaud C. et al. Plasma brain natriuretic peptide and cardiac troponin Ⅰ concentrations after adult cardiac surygery; association with postoperative cardiac dysfunction and 1 -year mortality[J]. Crit Care Med, 2006, 34 (4) :995 - 1000.
  • 9Kerbaul F, Giorgi R, Oddoze C. el al. High concentrations of N - BNP are related to non - infectious severe SIRS associated with cardiovascular dysfunction occurring after off - pump coronary artery surgery [J]. Br J Anaesth,2004.93(5):639- 644.
  • 10温绍君,王金城,张忱,张文,文杰,王佐广,刘洁琳,周其文.冠脉搭桥围手术期肿瘤坏死因子和内皮素的动态变化及意义[J].中华医学杂志,2001,81(23):1450-1452. 被引量:9

共引文献3

同被引文献33

  • 1Nishikimi T, Kuwahara K, Nakao K.Current biochemistry, molecular biology, and clinical relevance of natriuretic peptides. J Cardiol.2011;57(2):131-140.
  • 2Vanderheyden M, Vrints C, Verstreken S,et al.B-type natriuretic peptide as a marker of heart failure: new insights from biochemistry and clinical implications. Biomarkers in Medicine Vo1.2010; 4(2):315-320.
  • 3Inglis SC, Clark RA, McAlister FA,et al. Telemedicine and remote management of heart failure. Lancet. 2011 ;26:378.
  • 4van Veldhuisen D J, Linssen GC, Jaarsma T, et al. B-Type Natriuretic Peptide and Prognosis in Heart Failure Patients With Preserved and Reduced Ejection Fraction.J Am Coil Cardiol.2013;61 (14): 1498-1506.
  • 5Jae-Sik Jang; Han-Young Jin; Jeong-Sook Seo,et al. The role of brain natriuretic peptide-guided heart failure therapy: an updated meta-analysis.J Am Coil Cardiol. 2013;61 (10): 1264-1295.
  • 6Troughton RW, Lewis LK, Yandle TG, et al. B-type natriuretic peptides: looking to the future. Ann Meal.2011 ;43(3): 188-197.
  • 7Adamopoulos C, Meyer P, Desai RV, et ai. Absence of obesity paradox in patients with chronic heart failure and diabetes mellitus: a propensity-matched study. Eur J Heart Fail.2011; 13(2):200-206.
  • 8Lee R,Chan SP, Wong J,et al.lmpact of diabetes mellitus on. survival in South East Asian patients with congestive heart failure due to left ventricular systolic dysfunction.lnt J Cardiol. 2010;142(1):97-100.
  • 9Linskey K,Lewandrowski K.The role of B-type natriuretic peptide testing in patients with acute coronary syndromes. Minerva Cardioanqiol.2012;60(2): 175-182.
  • 10Chen TH, Lin CL, Shih JJ,et al. Plasma B-type natriuretic peptide in predicting outcomes of elective coronary artery bypass surgery. Kaohsiung J Med Sci.2013;29:254-258.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部